NCT05563272 2025-07-10STARBURSTTelix Pharmaceuticals (Innovations) Pty LimitedPhase 2 Terminated11 enrolled
NCT04190628 2024-05-21Safety and Tolerability of ABM-1310 in Patients With Advanced Solid TumorsABM Therapeutics CorporationPhase 1 Terminated53 enrolled
NCT02576665 2020-02-07A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)Tocagen Inc.Phase 1 Terminated21 enrolled
NCT02365662 2018-03-30A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorAbbViePhase 1 Terminated46 enrolled